Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA 3.75mg dose of Mounjaro requires five clicks to deliver. Each click of the KwikPen dispenses 0.75mg of tirzepatide, so five presses of the button release the full 3.75mg into the subcutaneous tissue. If you are counting clicks and feel uncertain whether your injection completed properly, that feeling is completely understandable — and this page explains exactly what to look for. Mounjaro is a prescription-only medicine; the dose you use and when you move between strengths is decided by your prescriber, not by the number on the box alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's licensed UK strengths are 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. You will notice that 3.75mg does not appear on that list as a named pen. So why are people counting to five clicks at 3.75mg? The answer is that each pre-filled KwikPen holds enough tirzepatide for four weekly injections at the labelled dose, but the pen can also be used to deliver a half-strength of the next tier. A 7.5mg pen, for example, contains a total of 30mg across four doses. Someone whose prescriber has recommended a 3.75mg increment during titration would draw five clicks from a 7.5mg pen, producing exactly 3.75mg, and our dedicated page on Mounjaro 3.75 clicks covers that process in full.
This approach is sometimes used to make a gentler step between doses, but it is not something to decide alone. The Mounjaro treatment overview explains the standard titration ladder and the clinical reasoning behind it. Your prescriber sets the dose; your job is to deliver it accurately.
The NHS patient information page for tirzepatide covers the general injection process and lists the standard strengths, which is a useful reference alongside your own Patient Information Leaflet.
Press the button on your KwikPen slowly and steadily. Each audible click is one 0.75mg increment being delivered. If you want to know how many clicks are needed for a 3.75mg Mounjaro dose, the short answer is five, and you should hear and feel each one distinctly before releasing the button. Keep the pen pressed against the injection site for a slow count of ten after the fifth click, this allows the full volume to enter the tissue rather than retreating back up the needle.
After releasing the button, check the plunger window on the side of the pen. If the grey plunger is visible and has moved, the dose delivered. If the window looks unchanged or the button did not travel fully, do not inject again immediately; contact your prescriber or pharmacist to discuss what happened. A second dose on the same day risks side effects from over-delivery, which is not a small concern with tirzepatide.
Rotate your injection site each week, abdomen, thigh and outer upper arm are all suitable. For a broader look at the injection technique itself, the Mounjaro injection guide walks through site choice, needle angle and aftercare in detail. Always change the needle before each injection; replacement needles compatible with the KwikPen are available if you need them.
Here is where the click count becomes secondary to something more important. Deciding to use 3.75mg (rather than staying at 2.5mg or moving fully to 5mg) is a clinical judgement. If a prescriber has explicitly written 3.75mg into your plan, follow their guidance and your Patient Information Leaflet. If you are considering adjusting your own dose between standard steps because of tolerability or impatience with progress, that is a conversation to have first.
The most common reason patients reach for a mid-step dose is gastrointestinal side effects at the full next strength, nausea, loose stools, or a general feeling of unwellness after a dose increase. Those effects are real, and they matter. What also matters is that a prescriber can weigh that against your current weight trajectory and suggest the approach most likely to keep you on treatment long-term. Titration is not just arithmetic; it is clinical assessment.
If you want to understand how many clicks are in a Mounjaro pen across all strengths, that page gives the full picture. For context on the cost of ongoing treatment as your dose changes, the guide to Mounjaro pricing in the UK explains what drives the variation between doses and providers.
A question our prescribers hear regularly: "I lost count halfway through, did I get the right dose?" The honest answer is that it is difficult to know for certain after the fact. If you think you may have under-injected, do not top up. If you think you may have over-injected, watch for intensified side effects and contact a clinician if anything concerns you. The frequently asked questions page covers common injection doubts, and the contact page is the quickest route to our clinical support team, available seven days a week.
Suspected side effects from any medicine can also be reported directly to the MHRA via the Yellow Card scheme, something worth knowing regardless of whether your concern relates to a dose count or a reaction.
If you are not yet on Mounjaro and are working out whether it might suit you, a free consultation with our prescribers is the right starting point. A real clinician (not software) reads your answers and reviews your suitability the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.